Patents by Inventor Ravinder Maini

Ravinder Maini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Suppression of TNFalpha and IL-12 in therapy
    Publication number: 20070178099
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed are compositions comprising a TNF antagonist and an IL-12 antagonist. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Application
    Filed: March 26, 2007
    Publication date: August 2, 2007
    Inventors: Marc Feldmann, Anne-Marie Malfait, Debra Butler, Fionula Brennan, Ravinder Maini
  • Methods for treating interleukin-6 related diseases
    Publication number: 20060251653
    Abstract: A pharmaceutical composition for the treatment of interleukin-6 (IL-6) related diseases, comprising an interleukin-6 antagonist (IL-6 antagonist) and immunosuppressants. The IL-6 antagonist is preferably an antibody to an interleukin-6 receptor (IL-6R).
    Type: Application
    Filed: April 28, 2004
    Publication date: November 9, 2006
    Applicant: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Osamu Okuda, Noriaki Yoshida, Ravinder Maini
  • TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
    Publication number: 20060099212
    Abstract: Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
    Type: Application
    Filed: September 12, 2005
    Publication date: May 11, 2006
    Inventors: Marc Feldmann, Ravinder Maini